1508

540975

ASTERDM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ASTER DM HEALTHCARE LTD. Share Price Today

ASTER DM HEALTHCARE LTD. is currently trading at ₹730.5, up by ₹3.54 from the previous close. The stock touched an intraday high of ₹736.00 and a low of ₹723.85 during the latest trading session. Over the past one year, ASTER DM HEALTHCARE LTD. has delivered a return of 31.43%, while the stock has declined 2.4% in the last one month.

ASTER DM HEALTHCARE LTD. performance

Today’s low Today’s high
₹ 723.85 ₹ 736.00
₹ 730.50
52 week low 52 week high
₹ 519.10 ₹ 776.55
₹ 730.50
Open Price ₹ 726.95
Prev. Close ₹ 726.95
Volume (Shares) 556755.00
Total traded value ₹ 4067.09
Upper Circuit ₹ 872.30
Lower Circuit ₹ 581.60
info

Investment Returns

Over 1 Month -2.40% Over 3 Months 12.77% Over 6 Months 9.33% Over 1 Year 31.43%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ASTER DM HEALTHCARE LTD. fundamentals


  • Market cap (Cr) 37,848.70
  • P/E Ratio (TTM) 140.64
  • Beta 0.36
  • Book Value / share 83.23
  • Return on equity 214.94%
  • EPS (TTM) 6.33
  • Dividend yield 0.41%
  • Net profit/quarter (Cr) 27.46
info icon alternate text
  • Market cap (Cr) 37,892.80
  • P/E Ratio (TTM) 140.64
  • Beta 0.28
  • Book Value / share 83.23
  • Return on equity 214.94%
  • EPS (TTM) 6.33
  • Dividend yield 0.41%
  • Net profit/quarter (Cr) 27.46
info icon alternate text

ASTER DM HEALTHCARE LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 655.10
Operating Expense 575.28
Net Profit 27.46
Net Profit Margin (%) 4.19
Earnings Per Share (EPS) 0.53
EBITDA 101.19
Effective Tax Rate (%) 35.60
Particulars DEC 2025 (Values in Cr)
Revenue 665.75
Operating Expense 598.62
Net Profit 55.16
Net Profit Margin (%) 8.28
Earnings Per Share (EPS) 1.07
EBITDA 152.66
Effective Tax Rate (%) 39.45
Particulars SEP 2025 (Values in Cr)
Revenue 681.81
Operating Expense 593.66
Net Profit 104.61
Net Profit Margin (%) 15.34
Earnings Per Share (EPS) 2.04
EBITDA 194.09
Effective Tax Rate (%) 21.00
Particulars JUN 2025 (Values in Cr)
Revenue 613.04
Operating Expense 539.05
Net Profit 80.59
Net Profit Margin (%) 13.14
Earnings Per Share (EPS) 1.58
EBITDA 167.55
Effective Tax Rate (%) 25.40
Particulars MAR 2025 (Values in Cr)
Revenue 573.86
Operating Expense 519.97
Net Profit 61.07
Net Profit Margin (%) 10.64
Earnings Per Share (EPS) 1.23
EBITDA 123.60
Effective Tax Rate (%) 2.44
Particulars MAR 2026 (Values in Cr)
Revenue 2615.70
Operating Expense 2306.61
Net Profit 267.82
Net Profit Margin (%) 10.23
Earnings Per Share (EPS) 5.20
EBITDA 615.49
Effective Tax Rate (%) 28.42
Particulars MAR 2025 (Values in Cr)
Revenue 2320.48
Operating Expense 2094.05
Net Profit 6208.97
Net Profit Margin (%) 267.57
Earnings Per Share (EPS) 124.67
EBITDA 6518.34
Effective Tax Rate (%) 1.26
Particulars MAR 2024 (Values in Cr)
Revenue 2036.50
Operating Expense 1876.17
Net Profit 156.96
Net Profit Margin (%) 7.70
Earnings Per Share (EPS) 3.15
EBITDA 409.10
Effective Tax Rate (%) 25.02
Particulars MAR 2023 (Values in Cr)
Revenue 1533.74
Operating Expense 1401.17
Net Profit 173.29
Net Profit Margin (%) 11.29
Earnings Per Share (EPS) 3.48
EBITDA 338.16
Effective Tax Rate (%) 4.95
Particulars MAR 2022 (Values in Cr)
Revenue 1116.47
Operating Expense 1108.71
Net Profit 90.18
Net Profit Margin (%) 8.07
Earnings Per Share (EPS) 1.81
EBITDA 232.70
Effective Tax Rate (%) -0.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 54.15
ROE % 9.07
ROCE % 11.56
Total Debt to Total Equity 0.47
EBITDA Margin 21.61
Particulars MAR 2024 (Values in Cr)
Book Value / Share 75.42
ROE % 5.70
ROCE % 4.78
Total Debt to Total Equity 0.87
EBITDA Margin 16.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 73.19
ROE % 13.14
ROCE % 2.96
Total Debt to Total Equity 1.33
EBITDA Margin 16.14
Particulars MAR 2022 (Values in Cr)
Book Value / Share 71.65
ROE % 17.05
ROCE % 10.51
Total Debt to Total Equity 1.33
EBITDA Margin 15.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 60.32
ROE % 5.10
ROCE % 5.88
Total Debt to Total Equity 1.57
EBITDA Margin 13.43
Particulars MAR 2025 (Values in Cr)
Book Value / Share 58.28
ROE % 214.94
ROCE % 147.31
Total Debt to Total Equity 0.31
EBITDA Margin 281.15
Particulars MAR 2024 (Values in Cr)
Book Value / Share 57.38
ROE % 5.62
ROCE % 7.37
Total Debt to Total Equity 0.24
EBITDA Margin 20.34
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.10
ROE % 6.36
ROCE % 6.40
Total Debt to Total Equity 0.20
EBITDA Margin 22.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 51.67
ROE % 3.23
ROCE % 3.93
Total Debt to Total Equity 0.16
EBITDA Margin 21.09
Particulars MAR 2021 (Values in Cr)
Book Value / Share 50.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin 8.50
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1380.00
Total Assets 6606.38
Total Liabilities 6606.38
Total Equity 3651.45
Share Outstanding 49
Price to Book Ratio 8.32
Return on Assets (%) 81.40
Return on Capital (%) 125.25
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 112.65
Total Assets 17991.31
Total Liabilities 17991.31
Total Equity 5030.11
Share Outstanding 49
Price to Book Ratio 7.13
Return on Assets (%) 0.71
Return on Capital (%) 2.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 428.56
Total Assets 14881.20
Total Liabilities 14881.20
Total Equity 4860.46
Share Outstanding 49
Price to Book Ratio 4.46
Return on Assets (%) 2.85
Return on Capital (%) 5.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 379.61
Total Assets 12546.24
Total Liabilities 12546.24
Total Equity 4482.62
Share Outstanding 49
Price to Book Ratio 3.81
Return on Assets (%) 4.19
Return on Capital (%) 7.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 281.36
Total Assets 11643.46
Total Liabilities 11643.46
Total Equity 3834.12
Share Outstanding 49
Price to Book Ratio 2.74
Return on Assets (%) 1.26
Return on Capital (%) 2.4
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1288.71
Total Assets 4964.76
Total Liabilities 4964.76
Total Equity 3339.49
Share Outstanding 49
Price to Book Ratio 8.32
Return on Assets (%) 125.06
Return on Capital (%) 167.05
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 34.85
Total Assets 4537.73
Total Liabilities 4537.73
Total Equity 3294.24
Share Outstanding 49
Price to Book Ratio 7.13
Return on Assets (%) 3.45
Return on Capital (%) 4.26
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 31.29
Total Assets 4102.07
Total Liabilities 4102.07
Total Equity 3130.56
Share Outstanding 49
Price to Book Ratio 4.46
Return on Assets (%) 4.22
Return on Capital (%) 4.99
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 25.02
Total Assets 3762.00
Total Liabilities 3762.00
Total Equity 2955.21
Share Outstanding 49
Price to Book Ratio 3.81
Return on Assets (%) 2.39
Return on Capital (%) 2.86
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 17.59
Total Assets 3588.62
Total Liabilities 3588.62
Total Equity 2864.11
Share Outstanding 49
Price to Book Ratio 2.74
Return on Assets (%) -1.91
Return on Capital (%) -2.27
Particulars MAR 2025 (Values in Cr)
Net Income 5542.26
Cash from Operations 539.56
Cash from Investing 6014.87
Cash from Financing -6357.81
Net change in Cash 82.11
Free Cash Flow 885.59
Particulars MAR 2024 (Values in Cr)
Net Income 330.30
Cash from Operations 229.07
Cash from Investing -884.65
Cash from Financing 1052.83
Net change in Cash 325.99
Free Cash Flow 1025.98
Particulars MAR 2023 (Values in Cr)
Net Income 535.09
Cash from Operations 1892.93
Cash from Investing -971.88
Cash from Financing -817.39
Net change in Cash 44.71
Free Cash Flow 2609.78
Particulars MAR 2022 (Values in Cr)
Net Income 636.85
Cash from Operations 1371.16
Cash from Investing -570.48
Cash from Financing -686.00
Net change in Cash 57.56
Free Cash Flow 1854.20
Particulars MAR 2021 (Values in Cr)
Net Income 205.05
Cash from Operations 1580.17
Cash from Investing -330.30
Cash from Financing -1116.13
Net change in Cash 122.69
Free Cash Flow 1984.43
Particulars MAR 2025 (Values in Cr)
Net Income 6288.25
Cash from Operations 433.68
Cash from Investing 6023.00
Cash from Financing -6298.11
Net change in Cash 92.12
Free Cash Flow 571.99
Particulars MAR 2024 (Values in Cr)
Net Income 209.35
Cash from Operations 444.50
Cash from Investing -342.32
Cash from Financing -67.09
Net change in Cash 3.34
Free Cash Flow 659.27
Particulars MAR 2023 (Values in Cr)
Net Income 182.33
Cash from Operations 261.63
Cash from Investing -331.95
Cash from Financing 92.20
Net change in Cash 6.11
Free Cash Flow 419.16
Particulars MAR 2022 (Values in Cr)
Net Income 89.96
Cash from Operations 82.74
Cash from Investing -49.17
Cash from Financing -17.69
Net change in Cash 11.48
Free Cash Flow 128.73
Particulars MAR 2021 (Values in Cr)
Net Income -68.78
Cash from Operations 51.13
Cash from Investing -38.07
Cash from Financing -12.35
Net change in Cash -8.76
Free Cash Flow 95.63
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8096.15 59.51 12.28 116410.22 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 53.30 24.12 2.90 99.89 40.75 77.00
SHREE PACETRONIX LTD. 130.50 15.57 2.74 48.93 66.10 283.15
TRANSGENE BIOTEK LTD. 3.09 0.00 2.79 23.41 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8096.15 77.54 11.68 116410.22 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 37.81 0.00 -9.20 28.24 30.30 57.48
KOVAI MEDICAL CENTER & HO 5337.25 23.88 4.42 5838.95 5010.00 6725.00

ASTER DM HEALTHCARE LTD. shareholding pattern

Holding
14.84%
40.39%
17.18%
27.57%
40.66%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

ASTER DM HEALTHCARE LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
730.50 0.48 redarrow
red-green-graph indicator
9 Bearish
7 Bullish
  • 5 Days 732.80
  • 26 Days 730.10
  • 10 Days 738.30
  • 50 Days 708.40
  • 12 Days 738.60
  • 100 Days 679.10
  • 20 Days 735.00
  • 200 Days 643.50
723.42 PIVOT
First Support 714.83 First Resistance 735.53 Second Support 702.72 Second Resistance 744.12 Third Support 694.13 Third Resistance 756.23
RSI 49.10 ADX 28.87 MACD 8.58 Williams % R -76.02 Commodity Channel Index (CCI) -147.67
Date 2026-06-02 Week 182789.00 Same Day 148193.00 Month 370856.00
1 Year 0.37 3 Year 0.46
Over 1 Month
-2.40% down
Over 1 Year
31.43% down
Over 3 Months
12.77% down
Over 3 Years
38.92% down
Over 6 Months
9.33% down
Over 5 Years
37.96% down

ASTER DM HEALTHCARE LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
02 Apr 2026 3.0 Interim 03 Apr 2026 Equity shares
28 Aug 2025 1.0 Final 28 Aug 2025 Equity shares
10 Feb 2025 4.0 Interim 10 Feb 2025 Equity shares
22 Aug 2024 2.0 Final 22 Aug 2024 Equity shares
23 Apr 2024 118.0 Special 23 Apr 2024 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
02 Apr 2026 3.0 Interim 03 Apr 2026 Equity shares
28 Aug 2025 1.0 Final 28 Aug 2025 Equity shares
10 Feb 2025 4.0 Interim 10 Feb 2025 Equity shares
22 Aug 2024 2.0 Final 22 Aug 2024 Equity shares
23 Apr 2024 118.0 Special 23 Apr 2024 Equity shares

Top Gainers

Top Losers

Aster DM Share Result Highlights

MetricValue
Aster DM share price₹495.55
Net Profit (Qtr)₹89.84 Cr
Revenue (Qtr)₹604.68 Cr
Operating Expense₹531.59 Cr
Net Profit Margin14.85%
Earnings Per Share₹1.80
EBITDA₹175.73 Cr
Effective Tax Rate25.02%

Key Highlights

  • Aster DM share price has decreased by ₹4.40 in the latest session.
  • The company reported a net profit of ₹89.84 Cr with a margin of 14.85%.
  • EBITDA stands at ₹175.73 Cr, reflecting solid operational efficiency.
  • Revenue for the quarter is ₹604.68 Cr, indicating stable business performance.

Aster DM Share Annual Reports

MetricValue
Revenue (Annual)₹2036.50 Cr
Operating Expense₹1876.17 Cr
Net Profit (Annual)₹156.96 Cr
Net Profit Margin7.70%
Earnings Per Share₹3.15
EBITDA₹409.10 Cr
Effective Tax Rate25.02%

Key Highlights

  • Aster DM share price has performed steadily with a net profit of ₹156.96 Cr and a profit margin of 7.70%.
  • EBITDA for the year is ₹409.10 Cr, with healthy operational control.
  • Earnings Per Share (EPS) stood at ₹3.15 for the year, reflecting positive financial growth.

Aster DM Share Dividend

MetricValue
Dividend Yield0.40%
Dividend per ShareNot specified

Key Highlights

  • The Aster DM share price is accompanied by a modest dividend yield of 0.40%.
  • Although the company offers a dividend, the exact per-share amount has not been specified.
  • The low dividend yield suggests a focus on reinvestment into the business for growth.

Popular FAQs

1. Who is the CEO of Aster DM Healthcare Ltd?

The CEO of Aster DM Healthcare Ltd is Dr. Nitish Shetty, who was appointed as the Chief Executive Officer of Aster DM Healthcare India effective April 1, 2023. He has been instrumental in overseeing the company's operations in India and driving its growth strategy.

 

2. When was Aster DM Healthcare Ltd established?

Aster DM Healthcare Ltd was established in 1987. The company began as a single doctor clinic in Dubai and has since expanded significantly, developing a network of hospitals, clinics, pharmacies, and laboratories across multiple countries, including the GCC states and India.

 

3. What factors influence the Aster DM Share Price?

Several factors influence the Aster DM share price, including the company’s financial performance, growth prospects, and market conditions. The demand for healthcare services in the GCC and India, regulatory changes, competition in the healthcare sector, and developments within the company, such as acquisitions and expansions, also play a critical role in shaping its stock price.

 

4. Is Aster DM Healthcare Ltd debt-free?

No, Aster DM Healthcare Ltd is not completely debt-free. Like many large organizations, it uses a combination of debt and equity to finance its operations and expansion. However, the company’s debt levels and financial health are regularly monitored to ensure stability and growth, with a focus on maintaining a manageable debt burden.

 

5. What is the CAGR of Aster DM Share?

The Compound Annual Growth Rate (CAGR) of the Aster DM share price over the past five years is 26%, while over the past three years it is 37%. This indicates a strong upward trend in its stock performance, reflecting the company’s consistent growth and positive market sentiment towards its business model and expansion plans.

 

6. How has the Aster DM Share Price performed over the past year?

Over the past year, the Aster DM share price has shown a growth of 24%. This performance highlights the resilience of the company even in the face of economic challenges and reflects continued demand for its healthcare services across the regions it serves.

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Aster DM Healthcare Ltd?

Answer Field

Aster DM Healthcare Ltd share price is for NSE ₹ 730.50 & for BSE ₹ 731.35 as on Jun 03 2026 03:30 PM.

What is the Market Cap of Aster DM Healthcare Ltd Share?

Answer Field

The market cap of Aster DM Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 03 2026 03:30 PM.

What is the 52 Week High and Low of Aster DM Healthcare Ltd?

Answer Field

The 52 Week High and Low of Aster DM Healthcare Ltd for NSE is ₹ 776.55 and ₹ 519.10 and for BSE is ₹ 776.15 and ₹ 519.80.

What is 1 year return for Aster DM Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 31.43%.

What is the P/E Ratio of Aster DM Healthcare Ltd Share?

Answer Field

As on Jun 03 2026 03:30 PM the price-to-earnings (PE) ratio for Aster DM Healthcare Ltd share is 140.64.

What is the PB ratio of Aster DM Healthcare Ltd Share?

Answer Field

As on Jun 03 2026 03:30 PM, the price-to-book (PB) ratio for Aster DM Healthcare Ltd share is 83.23.

How to Buy Aster DM Healthcare Ltd Share?

Answer Field

You can trade in Aster DM Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aster DM Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Aster DM Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aster DM Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

Who is the CEO of Aster DM Healthcare Ltd?

Answer Field

The CEO of Aster DM Healthcare Ltd is Dr. Nitish Shetty, who was appointed as the Chief Executive Officer of Aster DM Healthcare India effective April 1, 2023. He has been instrumental in overseeing the company's operations in India and driving its growth strategy.

When was Aster DM Healthcare Ltd established?

Answer Field

Aster DM Healthcare Ltd was established in 1987. The company began as a single doctor clinic in Dubai and has since expanded significantly, developing a network of hospitals, clinics, pharmacies, and laboratories across multiple countries, including the GCC states and India.

What factors influence the Aster DM Share Price?

Answer Field

Several factors influence the Aster DM share price, including the company’s financial performance, growth prospects, and market conditions. The demand for healthcare services in the GCC and India, regulatory changes, competition in the healthcare sector, and developments within the company, such as acquisitions and expansions, also play a critical role in shaping its stock price.

Is Aster DM Healthcare Ltd debt-free?

Answer Field

No, Aster DM Healthcare Ltd is not completely debt-free. Like many large organizations, it uses a combination of debt and equity to finance its operations and expansion. However, the company’s debt levels and financial health are regularly monitored to ensure stability and growth, with a focus on maintaining a manageable debt burden.

What is the CAGR of Aster DM Share?

Answer Field

The Compound Annual Growth Rate (CAGR) of the Aster DM share price over the past five years is 26%, while over the past three years it is 37%. This indicates a strong upward trend in its stock performance, reflecting the company’s consistent growth and positive market sentiment towards its business model and expansion plans.

How has the Aster DM Share Price performed over the past year?

Answer Field

Over the past year, the Aster DM share price has shown a growth of 24%. This performance highlights the resilience of the company even in the face of economic challenges and reflects continued demand for its healthcare services across the regions it serves.

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|